Ewha Birth and Growth Study (Birth Cohort)

Overview

Ongoing longitudinal birth cohort established at Mok-dong Hospital, Ewha Woman's University, Seoul, South Korea, between 2001 and 2006.

Full Title of Study: “Evaluation of Influencing Factors Affecting Childhood Metabolic Indicators in Korea (Repeated Measures Analysis; Longitudinal Birth Study)”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 2017

Detailed Description

Cohort composed of mothers, who visited to prenatal care between 24 and 28 weeks of gestation, between 2001 and 2006. After the child was born then, we collected information at birth outcome and conducted mail surveys at 6, 12, 18, and 24 months. Regular check-up was conducted at 3, 5, and every year after 7 years of age(last check up point: 15 years old). In check-up survey, after an 8-hour overnight fast, blood and urine samples (3 ml EDTA-blood and 5 ml serum) were obtained from subjects by venepuncture. following parameters were checked: physical growth, blood pressure. metabolic biomarker(Total cholesterol, HDl-cholesterol, TG(triglyceride), glucose, uric acid, etc.), K-CBCL(Korea-child behavior checklist), 24 hour recall method for nutrition, FFQ(Food Frequency Questionnaire), Questionnaires including Socio-economic status and physical activity.

Clinical Trial Outcome Measures

Primary Measures

  • Profile of participants received regular medical check-up and result feed back for growth development
    • Time Frame: 365days
    • Changes from baseline in physical growth using anthropometric measurement

Secondary Measures

  • Profile of participants received blood pressure measurement for pediatric hypertension
    • Time Frame: 365days
    • Changes from baseline in average blood pressure(mmHg, diastolic and systolic) as above the 95th percentile adjusted for sex, age, and height percentile

Participating in This Clinical Trial

Inclusion Criteria

  • Participants' mothers, who visited to prenatal care between 24 and 28 weeks of gestation. – An individual who can be followed up during the study period and is capable of complying with the study requirements Exclusion Criteria:

  • An individual thought to have difficulty participating in the study due to other reasons, based on the judgment of the investigator

Gender Eligibility: All

Minimum Age: 24 Weeks

Maximum Age: 17 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Ewha Womans University
  • Collaborator
    • National Research Foundation of Korea
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.